Avacta Share Discussion Threads

[billthebank] 21/5/2020 10:46

Wish the share price graph was loaded!!!!! Aaaaaarrrrgghhhh!!!

[riz000] 21/5/2020 10:44

@chickendinner no one is interested in ur sad little lonely life u stupid idiot, keep ur views to ur self we not interested 2 fingers for likes of u 😆

[chickndinner] 21/5/2020 10:44

Mate. Come on. We're only toying with you.

Can someone please pick up that dummy. RIZ has thrown it out of his pram again...

[losses] 21/5/2020 10:43

CHOO CHOO the train is about to leave...

[chickndinner] 21/5/2020 10:41

Has Rizla teef only just woken up and read of my early morning posts.

I can't stop laughing:-)

Sorry. PMSL

[riz000] 21/5/2020 10:39

@chickendinner stop talking shyt b4 i close ur mouth.

[grandmasterglitch] 21/5/2020 10:36

Is that the same Riz who held XTR from 0.3p down to 0.001?

[chickndinner] 21/5/2020 10:36

Looks like she's ready to blow. Next resistance support £1.60

Watch when this baby flys!

[1liam] 21/5/2020 10:34

Ticking up ;)

[rocket fuel] 21/5/2020 10:34

smart money moving in.

[chickndinner] 21/5/2020 10:18

Rocket Fuel. Well done for the repost of yesterday's RNS.

The game changer is in the wording. Many millions of tests per months over years not months to get healthy people back to work.

Also I think I read each test costs £25 each.

I dont think the market has woken up to this yet.

The more I keep reading the more I'm blown away.

I'm pretty much maxed out now.

Had another £3k top up yesterday.

I have other big shares in my portfolio which are up and tempted to sell but I would be getting greedy then.

Stay safe x

[chickndinner] 21/5/2020 10:05

Posters debating yesterday is it Medusa19 MED USA 19

MEDITERRANEAN USA 19?

Who cares...

Everyone will easily remember Medusa19.com

Another marketing masterpiece from the people behind Boohoo.

[rocket fuel] 21/5/2020 10:04

Did we have the business wire one posted already? can't remember and can't be bothered looking back:




Avacta and Medusa19 Enter Into a Distribution Agreement For COVID-19 Antigen Test
20/05/2020 8:50am
Business Wire

Avacta (LSE:AVCT)
Intraday Stock Chart

Thursday 21 May 2020

Global, exclusive, direct-to-consumer sales and marketing agreement for COVID-19 self-testing
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an exclusive distribution agreement with Medusa19 Limited (“Medusa19”) for direct-to-consumer sales of a saliva-based rapid test for the COVID-19 antigen.
Avacta recently announced a partnership with Cytiva (formerly GE Healthcare Life Sciences) to develop a saliva-based rapid antigen test to indicate whether a person has the COVID-19 infection which will be in the form of a simple test strip. The test is intended to give a result within minutes and for use by both healthcare professionals and consumers.
The Group has agreed an exclusive distribution agreement with Medusa19 for the supply of the COVID-19 rapid test direct to consumers globally, subject to the necessary regulatory approvals. Medusa19 has been established by Richard Hughes and Mahmud Kamani, both founder shareholders of Boohoo.com and shareholders of Avacta1, to build a global consumer self-testing business. Medusa19’s initial focus will be on COVID-19 home testing and it is currently investing in global e-commerce, logistics and customer support infrastructure in preparation for Avacta’s COVID-19 test launch. Medusa19 will also have non-exclusive rights to supply the tests to businesses for workforce testing. The distribution agreement includes a profit-sharing arrangement.
The global demand for rapid antigen tests, which will be critical to lockdown exit strategies around the world in order to get healthy, non-contagious people back to work, could be many millions of tests per month. There will also be an ongoing need for several years for this type of testing as the disease recurs.
Avacta recently announced that it rapidly developed Affimer reagents that detect the SARS-COV-2 virus spike protein and it has now supplied those to Cytiva for test development. The Group is intending to establish further rapid test strip manufacturing partners in anticipation of a very high demand for the COVID-19 antigen test.
Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented:
“I am delighted to have entered into this distribution agreement with Medusa19, which will provide a global route direct-to-consumer for Avacta’s rapid point-of-care COVID-19 antigen test. The potential size of this market, and the expected demand from businesses for workforce screening, is substantial.
The significant investment that Medusa19 is making in conjunction with the track records of the Medusa19 team, gives me great confidence in the rapid growth of direct-to-consumer sales of the Avacta COVID-19 test across the United Kingdom, European Union and the United States subject to the necessary regulatory approvals. I expect the commercial impact of this partnership to be very significant to Avacta.
I am looking forward to working with the Medusa19 team on commercialising the COVID-19 rapid test and other consumer diagnostic tests that Avacta develops in the future, in line with the Group’s Affimer diagnostics strategy.”
Richard Hughes and Mahmud Kamani, Founders of Medusa19 commented:
“We immediately recognised the global opportunity to distribute the simple and unique saliva-based COVID-19 rapid test being developed by Avacta based on their unique and powerful Affimer platform.
Medusa19 will enable end-to-end supply of these tests on a global basis subject to regulatory approval and manufacturing capacity which will be key. The enormous, world-wide demand for these tests requires a robust and scalable platform which we are in the process of creating. Hundreds of millions of tests are required and this demand will continue.
The test being created by Avacta and its partners is intended to enable an individual with the COVID-19 infection, whether they have symptoms or not, to be identified before antibodies have been generated by the body. Given this test will be saliva based, it could be used in airports, offices, factories and in the home environment, providing a result within minutes and with no requirement for medical supervision. It is potentially ground-breaking and a major step forward in the fight against COVID-19.
We look forward to working with Alastair and his team and to distributing other Avacta products as they become available in due course.”
1. Clare Hughes (wife of Richard Hughes) and Umar Mahmud Kamani (son of Mahmud Kamani).
This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

View source version on businesswire.com:
Zyme Communications (Trade and Regional Media)
Katie Odgaard
Tel: [phone]
[e-mail]

[chickndinner] 21/5/2020 10:01

Multi billion £ company in the making!

[chickndinner] 21/5/2020 09:58

I am excited!

What a share!!!

[pd103] 21/5/2020 09:56

doh - ta.

Calm before the storm ...

[chickndinner] 21/5/2020 09:54

medusa19.com

[pd103] 21/5/2020 09:51

chick: link please? thanks

[chickndinner] 21/5/2020 09:51

Obviously they are going to be flying off the shelves.

I think the RNS stated they will be producing millions a month.

They did not specify how many millions?

Also I read that each test will cost £25 each but if you are a business and buy in bulk you will receive a discount so I've registered my business as well.

Just trying to get my head around how massive this company is going to be!

Even if they only produced 1 million tests per month @ £25 each = £25 million each month.

I have exceeded my ISA limit now with GGP and AVCT and having to top up in my normal stocks and shares.

Going to be a lot of wealthy investors soon and to top it all off these tests can be done at home and results back in 10 minutes.

What a game changer.

Stay safe all x

[loafofbread] 21/5/2020 09:50

A long weekend gives plenty of time for another RNS Tuesday morning.

Any deal for our Neutralising Affimer/Ace 2 blocker should double the share price

[rocket fuel] 21/5/2020 09:45

go for a lay down, sapper, in a dark room.. and best put me on filter list and keep me there throughout, so I won't have to waste any time responding to any irksome, little moody digs, that you might throw about in my direction. ta and goodbye from me the filtered one

[chickndinner] 21/5/2020 09:41

melody9999. Great call. I've also registered me and my wife.

Not sure how it will work though?

Do people who register early get 1st dibs at buying them when they come onto the market?

I should imagine that's how it works right?